Literature DB >> 17350155

The role of beta93 Cys in the inhibition of Hb S fiber formation.

Kelly M Knee1, Catherine K Roden, Mark R Flory, Ishita Mukerji.   

Abstract

Recent studies have suggested that nitric oxide (NO) binding to hemoglobin (Hb) may lead to the inhibition of sickle cell fiber formation and the dissolution of sickle cell fibers. NO can react with Hb in at least 3 ways: 1) formation of Hb(II)NO, 2) formation of methemoglobin, and 3) formation of S-nitrosohemoglobin, through nitrosylation of the beta93 Cys residue. In this study, the role of beta93 Cys in the mechanism of sickle cell fiber inhibition is investigated through chemical modification with N-ethylmaleimide. UV resonance Raman, FT-IR and electrospray ionization mass spectroscopic methods in conjunction with equilibrium solubility and kinetic studies are used to characterize the effect of beta93 Cys modification on Hb S fiber formation. Both FT-IR spectroscopy and electrospray mass spectrometry results demonstrate that modification can occur at both the beta93 and alpha104 Cys residues under relatively mild reaction conditions. Equilibrium solubility measurements reveal that singly-modified Hb at the beta93 position leads to increased amounts of fiber formation relative to unmodified or doubly-modified Hb S. Kinetic studies confirm that modification of only the beta93 residue leads to a faster onset of polymerization. UV resonance Raman results indicate that modification of the alpha104 residue in addition to the beta93 residue significantly perturbs the alpha(1)beta(2) interface, while modification of only beta93 does not. These results in conjunction with the equilibrium solubility and kinetic measurements are suggestive that modification of the alpha104 Cys residue and not the beta93 Cys residue leads to T-state destabilization and inhibition of fiber formation. These findings have implications for understanding the mechanism of NO binding to Hb and NO inhibition of Hb S fiber formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17350155      PMCID: PMC4743648          DOI: 10.1016/j.bpc.2007.02.002

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  61 in total

1.  Responses of normal and sickle cell hemoglobin to S-nitroscysteine: implications for therapeutic applications of NO in treatment of sickle cell disease.

Authors:  Celia Bonaventura; Gerald Godette; Giulia Ferruzzi; Shirley Tesh; Robert D Stevens; Robert Henkens
Journal:  Biophys Chem       Date:  2002-07-10       Impact factor: 2.352

2.  Solubility of fluoromethemoglobin S: effect of phosphate and temperature on polymerization.

Authors:  M E Yohe; K M Sheffield; I Mukerji
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

3.  Time resolved absorption study of the reaction of hydroxyurea with sickle cell hemoglobin.

Authors:  D B Kim-Shapiro; S B King; C L Bonifant; C P Kolibash; S K Ballas
Journal:  Biochim Biophys Acta       Date:  1998-03-12

4.  Quaternary structure sensitive tyrosine residues in human hemoglobin: UV resonance raman studies of mutants at alpha140, beta35, and beta145 tyrosine.

Authors:  M Nagai; H Wajcman; A Lahary; T Nakatsukasa; S Nagatomo; T Kitagawa
Journal:  Biochemistry       Date:  1999-01-26       Impact factor: 3.162

5.  Stereochemistry of cooperative mechanisms in hemoglobin.

Authors:  M F Perutz; G Fermi; B Luisi; B Shaanan; R C Liddington
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1987

Review 6.  Hemoglobin S gelation and sickle cell disease.

Authors:  W A Eaton; J Hofrichter
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

7.  Refined crystal structure of deoxyhemoglobin S. I. Restrained least-squares refinement at 3.0-A resolution.

Authors:  E A Padlan; W E Love
Journal:  J Biol Chem       Date:  1985-07-15       Impact factor: 5.157

8.  Studies on the chemistry of hemoglobin. I. The reactive sulfhydryl groups.

Authors:  G Guidotti
Journal:  J Biol Chem       Date:  1967-08-25       Impact factor: 5.157

9.  Tyrosine hydrogen-bonding and environmental effects in proteins probed by ultraviolet resonance Raman spectroscopy.

Authors:  P G Hildebrandt; R A Copeland; T G Spiro; J Otlewski; M Laskowski; F G Prendergast
Journal:  Biochemistry       Date:  1988-07-26       Impact factor: 3.162

10.  Ligand binding properties and structural studies of recombinant and chemically modified hemoglobins altered at beta 93 cysteine.

Authors:  Yi Cheng; Tong-Jian Shen; Virgil Simplaceanu; Chien Ho
Journal:  Biochemistry       Date:  2002-10-01       Impact factor: 3.162

View more
  4 in total

1.  Targeting βCys93 in hemoglobin S with an antisickling agent possessing dual allosteric and antioxidant effects.

Authors:  Tigist Kassa; M B Strader; Akito Nakagawa; Warren M Zapol; Abdu I Alayash
Journal:  Metallomics       Date:  2017-09-20       Impact factor: 4.526

2.  Formation of amyloid fibrils in vitro from partially unfolded intermediates of human gammaC-crystallin.

Authors:  Yongting Wang; Sarah Petty; Amy Trojanowski; Kelly Knee; Daniel Goulet; Ishita Mukerji; Jonathan King
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-13       Impact factor: 4.799

3.  Methemoglobin Formation and Characterization of Hemoglobin Adducts of Carcinogenic Aromatic Amines and Heterocyclic Aromatic Amines.

Authors:  Khyatiben V Pathak; Ting-Lan Chiu; Elizabeth Ambrose Amin; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2016-02-22       Impact factor: 3.739

4.  Identification of a small molecule that increases hemoglobin oxygen affinity and reduces SS erythrocyte sickling.

Authors:  Akito Nakagawa; Francine E Lui; Dina Wassaf; Revital Yefidoff-Freedman; Dominick Casalena; Michelle A Palmer; Jacqueline Meadows; Andrea Mozzarelli; Luca Ronda; Osheiza Abdulmalik; Kenneth D Bloch; Martin K Safo; Warren M Zapol
Journal:  ACS Chem Biol       Date:  2014-08-11       Impact factor: 5.100

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.